Reference : Towards a Belgian Consensus for prevention of perinatal group B streptococcal disease
Scientific congresses and symposiums : Unpublished conference
Human health sciences : Pediatrics
Human health sciences : Laboratory medicine & medical technology
Human health sciences : Reproductive medicine (gynecology, andrology, obstetrics)
Human health sciences : Immunology & infectious disease
http://hdl.handle.net/2268/68458
Towards a Belgian Consensus for prevention of perinatal group B streptococcal disease
English
MELIN, Pierrette mailto [Centre Hospitalier Universitaire de Liège - CHU > > Microbiologie médicale >]
Verschraegen, G. [Hôpital universitaire de Gand - RUG > Microbiologie médicale > > >]
Mahieu, Ludo [Hôpital universitaire d'Anvers - UIA > Néonatologie > > >]
Claeys, G. [Hôpital universitaire de Gand - RUG > Bactériologie médicale > > >]
De Mol, Patrick mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Microbiologie médicale et virologie médicale >]
Oct-2002
Yes
No
International
XV Lancefield International Symposium on Streptococci and Streptococcal Diseases (LISSSD)
du 6 au 11 octobre 2002
LISSSD Board
Goa
Indes
[en] Group B streptococci ; perinatal infections ; Prevention ; consensus ; Belgium
[en] Background & objectives: In Belgium, as in many other countries, group B Streptococcus (GBS) is still
the leading cause of sepsis and meningitis in neonates. In 2001, though no Belgian guidelines for their
prevention were available, in some hospitals, obstetrical programmes included a GBS prevention
policy. With an aim to reach a Belgian consensus for the prevention of perinatal group B streptococcal
disease, a national consensum meeting was organized in 2001. We report here our experience and
findings of this meeting.
Methods: In November 2001, obstetricians, neonatologists, microbiologists and infectious diseases
specialists were invited to participate in a GBS symposium. International and Belgian speakers
presented epidemiological aspects, argued comparative cost-effectiveness of different approaches for
prevention and debated technical and practical problems. Management of neonates with risk factors
for GBS disease and progress in GBS vaccines were also included in the programme. Further results
about Belgian obstetricians’ practice and compliance to a policy for prevention of neonatal GBS
diseases, as answered in two mail surveys, were commented and discussed. In an interactive session at
the end, each participant was asked to vote on the key points related to the different steps of the ideal
prevention strategy to recommend.
Results: For the main questions, 94 per cent of participants choose a screening-based approach and
94 per cent shifted from the current use of ampicillin to penicillin as first choice for antimicrobial
prophylaxis. Further, 79 per cent voted for an approach with integrated neonatal prophylaxis for
selected neonates at high risk for GBS disease and 47 per cent voted for a strategy based on an
intrapartum rapid screening-based approach.
Interpretation & conclusion: The state of the question by different speakers, the data from Belgian
epidemiology, and the debate about cost-effectiveness of different approaches led to a massive vote in
favour of the universal screening-based approach. Based on these results, a working group has been
appointed by the Ministry of Health to draft and edit Belgian recommendations for the prevention of
perinatal GBS disease.
Professionals
http://hdl.handle.net/2268/68458

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
LISSSD 2002.GBS.pmelin.pdfPublisher postprint372.71 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.